American Journal on Addictions

Article	Citations
Internet Addiction Increases in the General Population During COVID‐19: Evidence From China	115
Microinduction of Buprenorphine/Naloxone: A Review of the Literature	71
Increasing Heroin‐Methamphetamine (Goofball) Use and Related Morbidity Among Seattle Area People Who Inject Drugs	46
Patients' perceptions of telehealth services for outpatient treatment of substance use disorders during the COVID‐19 pandemic	42
Examining Associations Between Licensed and Unlicensed Outlet Density and Cannabis Outcomes From Preopening to Postopening of Recreational Cannabis Outlets	24
Prevalence of problematic Internet use and its association with quality of life among undergraduate nursing students in the later stage of COVID‐19 pandemic era in China	22
Review Article: Anabolic‐Androgenic Steroids, Violence, and Crime: Two Cases and Literature Review	22
Development and Feasibility Study of an Addiction‐Focused Phenotyping Assessment Battery	21
Are x‐waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x‐waiver trainings	20
Substance use, depression, and loneliness among American veterans during the COVID‐19 pandemic	19
Characteristics of xylazine‐related deaths in West Virginia—Xylazine‐related deaths	16
Open‐label trial of a single‐day induction onto buprenorphine extended‐release injection for users of heroin and fentanyl	15
Cannabis use disorder and increased risk of arrhythmia‐related hospitalization in young adults	14
Brief Report: The Impact of COVID‐19 on Emergency Department Overdose Diagnoses and County Overdose Deaths	14
A longitudinal study on the impact of Internet gaming disorder on self‐perceived health, academic performance, and social life of first‐year college students	13
Case Series: Cariprazine for treatment of methamphetamine use disorder	12
Admissions to substance use treatment facilities for cannabis use disorder, 2000–2017: Does legalization matter?	12
Sleep and substance use disorder treatment: A preliminary study of subjective and objective assessment of sleep during an intensive outpatient program	12
Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex	11
Seeing is believing: How cannabis marketing exposure is associated with cannabis use attitudes and behavior in a permissive medical cannabis policy environment	11
Chronic Pain Among Patients With an Opioid Use Disorder	10
Trends in substance use disorder diagnoses among Veterans, 2009–2019	10
A Healthcare System‐Level Intervention to Increase Naloxone Availability for Patients With Opioid Prescriptions	10
Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders	9
Systematic review: Rates of psychopathology, substance misuse, and neuropsychological dysfunction among transitional age youth experiencing homelessness	8

Food insecurity risk and alcohol use disorder in US young adults: Findings from the National Longitudinal Study of Adolescent to Adult Health	8
Single‐use, co‐use, and polysubstance use of alcohol, tobacco, and cannabis in sexual minority and heterosexual females	8
Nicotine Inhalation and Suicide: Clinical Correlates and Behavioral Mechanisms	8
β‐Arrestin 2 (ARRB2) Polymorphism is Associated With Adverse Consequences of Chronic Heroin Use	7
A Comparison of Mental and Behavioral Health Risks Factors Associated With Current Dual Use of Electronic Cigarette and Conventional Tobacco Cigarettes With Exclusive Tobacco Cigarette Use and Nonuse	7
Congenital syphilis prevention in the context of methamphetamine use and homelessness	6
Effects of 28 days of cannabis abstinence on cognition in major depressive disorder: A pilot study	6
Cigarette, e‐cigarette, and dual use during the third trimester of pregnancy in a national sample of heterosexual and sexual minority women	6
Main and Interactive Effects of Nicotine Product Type on Sleep Health Among Dual Combustible and E‐Cigarette Users	6
Prevalence, correlates, and consequences of attention‐deficit/hyperactivity disorder in a clinical sample of adults with tramadol use in Egypt	6
Women's and men's experiences in group therapy for substance use disorders: A qualitative analysis	6
Reduced alcohol use in patients prescribed pioglitazone	6
Examination of Correlates of OUD Outcomes in Young Adults: Secondary Analysis From the XBOT Trial	6
Commentary: It Is Not About Supply, It Is About Demand: Why the Self‐Medication Hypotheses Is Still So Important	6
Systematic Review and Meta‐Analysis: Treatment of Substance Use Disorder in Attention Deficit Hyperactivity Disorder	6
Essential components of physician health program monitoring for substance use disorder: A survey of participants 5 years post successful program completion	6
Alcohol and marijuana co‐use among adults with chronic low back pain: Associations with substance misuse, mental health, and pain experience	6
Binge drinking and sexual risk behavior among US sexual and gender minority college students	6
The Efficacy of Combined Electroacupuncture and Auricular Pressure on Sleep Quality in Patients Receiving Methadone Maintenance Treatment	6
Opioid use disorder at delivery hospitalization in the United States: 2012–2016	5
Factors associated with readmission to alcohol and opioid detoxification in the Alaska Interior	5
Alcohol use at the intersection of sexual orientation and gender identity in a representative sample of youth in Colorado	5
Faith leaders’ perceptions of needle exchange programs in the rural Illinois Delta Region: Religion as a social determinant of health	5
Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the O	5
Characterizing autistic traits in treatment‐seeking young adults with substance use disorders	5
Systematic review: Wearable remote monitoring to detect nonalcohol/nonnicotine‐related substance use disorder symptoms	5
A cross‐sectional study: Nitrous oxide abuse in Parisian medical students	5
A systematic review of virtual reality therapies for substance use disorders: Impact on secondary treatment outcomes	5
	5
Gender differences among persons entering medication treatment for opioid use disorder in the community	5
Clinical correlates of drug‐related dreams in opioid use disorder	5
Opioid use disorder and its association with self‐reported difficulties participating in social activities	4
Medication treatment for alcohol use disorder in special populations	4
Cingulate Cortex Structural Alterations in Substance Use Disorder Psychiatric Inpatients	4
A pilot test of Written Exposure Therapy for PTSD in residential substance use treatment	4
Buprenorphine treatment retention and comorbidities among patients with opioid use disorder in a primary care setting	4
Correlates of optimism among patients in substance use disorder inpatient treatment	4
Demographic, Behavioral, and Proximal Risk Factors for Gambling Disorder in the US Military	4
Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs	4
Associations between alcohol and cannabis use order, frequency, quantity, and consequences in a college sample of individuals who co‐use alcohol and cannabis	4
Legalization of cannabis in Canada—Local media analysis	4
CME Posters (n = 64)	4
Brief Report: Expectancies for alcohol analgesia are associated with greater alcohol use among moderate‐to‐heavy drinkers without chronic pain	4
The association between adverse childhood experiences and treatment response for adults with alcohol and other drug use disorders	4
Brief Report: Predictors of Relapse for Patients With Dextromethorphan Dependence	4
Substance use disorders and treatment in Asian American and Pacific Islander women: A scoping review	4
	3
Did the 2021 federal change in the practice guidelines for the administration of buprenorphine for treating opioid use disorder increase buprenorphine prescription dispensing in Medicaid population?	3
Effects of a trauma‐informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof‐of‐concept study	3
Comprehensive analysis of discharge reasons from methadone outpatient treatment programs	3

Improvements in recovery capital are associated with decreased alcohol use in a primary opioid use disorder treatment‐seeking cohort	3
	3
Assessing the quality of publicly available videos on MDMA‐assisted psychotherapy for PTSD	3
Outcomes associated with once‐daily versus multiple‐daily dosing of buprenorphine/naloxone for opioid use disorder	3
Sexual minority disparities in opioid and benzodiazepine misuse among adults with opioid use disorder	3
Parental influences on tobacco use and likelihood of future use among sexual minority young adult men and women in the United States	3
Drugs and bugs: Negative affect, psychostimulant use and withdrawal, and the microbiome	3
	3
Systematic review and meta‐analysis: Combining transcranial magnetic stimulation or direct current stimulation with pharmacotherapy for treatment of substance use disorders	3
Alcohol use and alcohol‐related consequences based on gender and sexual orientation among college students	3
Substance use treatment services utilization and outcomes among probationers in drug courts compared to a matched cohort of probationers in traditional courts	3
Risk of Relapse Among Opioid‐Dependent Patients Treated With Extended‐Release Naltrexone or Buprenorphine‐Naloxone: A Randomized Clinical Trial	2
Prescription Drug Monitoring Program: Access in the First Year	2
Age of gambling onset and resultant gambling behavior during young adulthood in the United States	2
Persistence of Operant Responding for Food After Prior Cocaine Exposure in Fischer 344 But Not Lewis Rats	2
Trajectories of depression among patients in treatment for opioid use disorder: A growth mixture model secondary analysis of the XBOT trial	2
	2
Cocaine history and impulsiveness in professional boxers and mixed martial arts fighters	2
Trajectories of prescription opioid and heroin use in adulthood	2
Illegal behaviors as a consequence of gambling disorder	2
Daily cannabis use may cause cannabis‐induced hyperalgesia	2
Comparing substance use treatment initiation and retention between telehealth delivered during COVID‐19 and in‐person treatment pre‐COVID‐19	2
Ketamine use in relation to depressive symptoms among high school seniors	2
Patients' experiences with continuation or discontinuation of buprenorphine before painful procedures: A brief report	2
Addiction specialists' attitudes toward psychedelics: A National Survey	2
Hazardous Alcohol Use, Impulsivity, and HIV‐Risk Behavior Among HIV‐Positive Russian Patients With a History of Injection Drug Use	2
Cognitive improvement among abstinent methamphetamine users: A 2‐year prospective longitudinal study	2
Treatment utilization and modality preference among veterans receiving outpatient substance use disorder treatment during a pandemic	2
Factors associated with dual and polytobacco use among people in residential substance use disorder treatment	2
Substance Use, Gambling, Binge‐Eating, and Hypersexuality Symptoms Among Patients Receiving Opioid Agonist Therapies	2
Sensitivity of health records for self‐reported nonfatal drug and alcohol overdose	2
Polysubstance use profiles among US adults using Kratom (Mitragyna speciosa): A latent class analysis using The National Survey on Drug Use and Health (NSDUH)	2
Associations of cannabis use frequency and cannabis use disorder with receiving a substance use screen and healthcare professional discussion of substance use	1
The impact of body image dissatisfaction on psychological distress and health‐related quality of life among patients in methadone treatment	1
Conference Schedule	1
Tobacco/nicotine use among individuals using cannabis for therapeutic purposes	1
Barriers to recovery for medical professionals: Assessing financial support through a survey of Physician Health Programs	1
Racial/ethnic discrimination, ADH1B*3, and coping‐motivated drinking among Black college students	1
Regional differences in fatal drug overdose deaths among Black and White individuals in the United States, 2012–2021	1
Brief report: The influence of childhood trauma on the effects of delta‐9‐tetrahydrocannabinol in persons with opioid use disorder	1
Concurrent Paper Sessions	1
Feasibility and preliminary efficacy of a community support intervention for people with opioid use disorder	1
Risk factors for poor progression of addictive internet use across different COVID‐19 periods in China	1
Symposia, Case Conference, Medical Update, and Case Summaries	1
Stand against stigma	1
Extended‐release buprenorphine in pregnancy	1
Impact of state and trait anxiety severity on retention and phase advancement in an outpatient buprenorphine treatment program	1
	1
Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine‐naloxone (BUP‐NX) or extended‐release naltrexone (XR‐NTX) for opioid use disorder	1
Obsessive‐compulsive disorder in Chinese methamphetamine patients: Prevalence, demographics, and clinical characteristics	1
Anxiety sensitivity and cannabis use motives among trauma‐exposed young adult cannabis users	1
Opioid use disorder in the active service: Implications for intervention	1
Call for special issue 2023	1
Narcotics Anonymous members in recovery from methamphetamine use disorder	1
Averting neonatal abstinence syndrome and treating addiction among rural, opioid‐using young women	1
Predictors of abstinence maintenance after cocaine inpatient detoxification: A prospective study	1
Motives for prescription opioid use: The role of alexithymia and distress tolerance	1
Unfilled prescriptions: Surveying patients' experiences with buprenorphine treatment in Massachusetts before and during the COVID‐19 pandemic	1
Unmet mental health need and subsequent substance use in individuals with a history of depression: Are there differences between metro and nonmetro areas?	1
Barriers for recruitment to treatment of youths with co‐occurring substance use disorders and depression	1
Impact of an opioid prescribing alert system on patients with posttraumatic stress disorder	1
	1
Predictors of protein intake among people who inject drugs in Los Angeles and San Francisco, California	1
A call for increased addiction psychiatrist engagement in medical student education	1
Evaluating the substance use disorder treatment gap in the United States, 2016−2019: A population health observational study	1
Educating the community about the opioid epidemic and medications for opioid use disorder	1
Alcohol and cannabis dual use among Black adults: Associations with alcohol use, use‐related problems, and race‐based discrimination	1
Medical marijuana access and prolonged opioid use among adolescents and young adults	1
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center	1
AAAP PIPs 2022	1
Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder	1
Sleep disturbance in clients attending a specialist addiction clinic	1
Relapse risk factors for patients with comorbid affective disorders and substance abuse disorders from an intensive treatment unit	1
Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia‐spectrum disorders?	1
Social vulnerability predictors of drug poisoning mortality: A machine learning analysis in the United States	1
Variables associated with methamphetamine use within the past year and sex differences among patients with methamphetamine use disorder: A cross‐sectional study in Japan	1
	1
Marijuana use disorder among adults with functional disabilities—A US population‐based cross‐sectional study	1
Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended‐release naltrexone in a residential setting	1
Case series: Voluntary discontinuation of sublingual buprenorphine treatment for opioid use disorder using extended‐release buprenorphine	1

Emotional regulation in Gaming Disorder: A systematic review	1
Call for Review Papers 2024	0
Retrieve your CME from AAAPs Annual Meeting AAAPs Self‐Assessment Examination 2020	0
Are DEA‐waivered buprenorphine prescribers colocated with behavioral health clinicians?	0
	0
The possible clinical utility of the alcohol biomarker phosphatidylethanol for managing suspected alcohol withdrawal in hospitalized patients: A case report	0
Call for special issue 2023	0
AAAP PIPS 2023	0
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada	0
Save the Date AM 2024	0
AAAP 36th Annual Meeting & Scientific Symposium Save the Date	0
Is buprenorphine maternal dose associated with neonatal opioid withdrawal syndrome severity?	0
Issue Information ‐ ToC	0
AATT AAP on‐demand	0
	0
Addiction Psychiatry Advanced Psychotherapy Curriculum	0
Issue Information	0
AAAP on‐demand educational activities	0
Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo‐controlled crossover laboratory study	0
Registration is Open for AAAP's 31st Annual Meeting and Scientific Symposium	0
Issue Information	0
Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine	0
Treatment Goals and Alcohol Use Outcomes in Veterans With Comorbid Alcohol Dependence and Posttraumatic Stress Disorder	0
Discounted Rate for CME Self Assessment for ABPN Diplomates	0
Call for review papers 2023	0
AAAP Annual Meeting Save the Date	0
Issue Information	0
Issue Information ‐ Editorial Board	0
Call for review papers 2023	0
Medication Management for Stimulant Use Disorder Webinar	0
Call for review papers 2022	0
Self assessment ad (002)	0
	0
Issue Information	0
Dissociation of drug and negative emotional cue induced attentional bias in individuals with methamphetamine‐use disorder	0
Renew Your AAAP Membership	0
Years of life lost to drug overdose in the Latinx community during the most recent wave of overdose deaths	0
Issue Information	0
Motivational Interviewing PIP	0
Alcohol use disorder, cannabis use disorder, and eating disorder symptoms among male and female college students	0
Do veterans with risky substance use (RSU) use distinct pain treatment modalities?	0
Mini‐Symposia II	0
Age and gender differences in motives for z‐drug misuse: Findings from the 2015 to 2019 NSDUH survey	0
Issue Information ‐ Editorial Board	0
Issue Information ‐ Editorial Board	0
AAAP's Annual Meeting and Scientific Symposium	0
Availability of substance use disorder treatment in Spanish: Associations with state‐level proportions of Spanish speakers and treatment facility characteristics in the United States	0
2024 Annual Meeting Posters	0
AAAP's Product Portal	0
Issue Information ‐ Editorial Board	0
Impact of inpatient addiction psychiatry consultation on opioid use disorder outcomes	0
Is your AAAP membership expiring soon?	0
Call for review papers 2023	0
Addiction Psychiatry Advanced Psychotherapy Curriculum	0
Issue Information ‐ ToC	0
CSAM‐SMCA 2022 Scientific conference and annual meeting	0
Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients	0
Trends in cocaine use among United States females of reproductive age, 2005–2019	0
Call for special issue 2022	0
AATT & AAP	0
Call for special issue 2022	0
Factors associated with daily use of benzodiazepines/tranquilizers and opioids among people who use drugs	0
Associations between muscle‐building exercise and alcohol use behaviors among adolescent boys: Results from the 2019 Youth Risk Behavior Survey	0
Issue Information	0
Call for review papers 2023	0
2022: The Year in Review	0
Exploring the intersection of sexual identity and route of administration in relation to cannabis use among young adult females	0
2023 Reviewer List (n = 223)	0
Cannabis Use PIP Ad	0
AAAP_Call for Special Issue Papers‐2024	0
Become a AAAP Member	0
Symposium I	0
Time spent on social media and depressive symptoms in university students: The mediating role of psychoactive substances	0
Become a member of AAAP!	0
The prevalence and treatment utilization of substance use disorders among Muslims in the United States: A national epidemiological survey	0
Issue Information	0
Stand against stigma	0
AAAP Podcast Series, Episode 10: Discussion on Cybersecurity with Norma Krayem	0
Issue Information ‐ ToC	0
Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan‐Canadian, randomized control trial	0
Issue Information ‐ ToC	0
Issue Information	0
Two‐part models identifying predictors of cigarette, e‐cigarette, and cannabis use and change in use over time among young adults in the US	0
Is your AAAP Membership expiring this month?	0
Call for Review Papers	0
Stimulants PIP Ad	0
Call for Special Issue 2024	0
Issue Information	0
Psychotherapy webinar series AJA Ad	0
2022 Self‐Assessment examination	0
Gender differences in the prevalence of stimulant misuse in the United States: 2015–2019	0
AAAP Annual meeting ad	0
Issue Information ‐ ToC	0
AJA Stand Against Stigma	0
Call for Review Papers 2023	0